coherentmarketblogs

Androgen deprivation therapy: Androgen deprivation therapy (ADT) is a hormone therapy for prostate cancer in men that works by removing excess androgen from the body. In testosterone and dihydrotestosterone, androgen is a sex hormone generated in the testes and adrenal gland. Androgen deprivation therapy involves removing androgen from the body to reduce adverse effects such as increasing cancer cell proliferation in the early stages and modulating androgen functions. To treat intermediate and high-risk prostate cancer, androgen deprivation therapy is combined with external beam radiotherapy. Market Analysis: The global Androgen Deprivation Therapy (ADT) Market is expected to grow at a CAGR of 5.0 per cent from USD 5647 million in 2019 to USD 7971.1 million by 2026, up from USD 5647 million in 2019. The global androgen deprivation therapy market is being propelled forward by rising prostate cancer cases and fatalities, breakthrough technologies, expanding healthcare expenditure and fa